Draft:TempoPay
Submission declined on 12 September 2026 by DoubleGrazing (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. Cboudreau87 (talk) 17:07, 29 July 2026 (UTC)
| Type | Private |
|---|---|
| Founded | 2022 |
| Headquarters | |
| Key people | Tom Policelli, CEO |
| Parent | Health Payment Systems, Inc. |
| Website | https://tempopay.com/ |
TempoPay is an American financial technology company that provides healthcare financing. Founded in 2022 and headquartered in Milwaukee, Wisconsin, the company offers a platform through which members arrange repayment plans for healthcare costs. Its customers include employers, health plans, and brokers.[1]
History
In 2024, TempoPay was acquired by Health Payment Systems (HPS/PayMedix).[2]
In 2025, the company introduced TempoPay Rx, a financing product intended to help individuals pay for prescription medications, which it positioned as a response to cost-related medication non-adherence.[3]
References
[edit]- ↑ "TempoPay - Products, Competitors, Financials, Employees, Headquarters Locations". CB Insights. Retrieved 2026-07-29.
- ↑ PYMNTS (2024-08-06). "HPS/PayMedix Acquires TempoPay, Widening Access to Healthcare Financing | PYMNTS.com". PYMNTS.com. Retrieved 2026-07-29.
- ↑ Pennic, Fred (2025-04-30). "TempoPay Launches Rx Financing Solution to Combat Prescription Non-Adherence Due to Cost". Retrieved 2026-07-29.

- provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.